Skip to main content
SD BIOSENSOR INC. logo

SD BIOSENSOR INC. — Investor Relations & Filings

Ticker · 137310 ISIN · KR7137310009 KO Manufacturing
Open in API
Filings indexed 337 across all filing types
Latest filing 2024-01-23 Director's Dealing
Country KR South Korea
Listing KO 137310

About SD BIOSENSOR INC.

https://www.sdbiosensor.com/

SD BIOSENSOR INC. is an in-vitro diagnostics company that develops, manufactures, and supplies point-of-care (POC) diagnostic solutions. The company specializes in rapid diagnostic tests (RDTs), biosensors, and diagnostic reagents aimed at the early and accurate diagnosis, prevention, and management of diseases. A key product is the STANDARD M, a point-of-care molecular diagnostics (MDx) system designed for fast and simple clinical decision-making near the patient. Through its focus on innovative biosensor technology, the company aims to improve the quality of life by providing accessible and reliable diagnostic tools.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Director's Dealing Classification · 1% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) filed by SD Biosensor. It details specific changes in share ownership by company executives (e.g., Lee Hyo-keun) and major shareholders. This type of filing is a standard regulatory disclosure for insider transactions and changes in major shareholding positions, which falls under the 'Director's Dealing' category as it reports personal share transactions by company directors and executives.
2024-01-23 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 1% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for SD Biosensor. It details specific changes in share ownership by individuals classified as major shareholders or related parties (e.g., Cho Byung-ki). This type of filing is a standard regulatory requirement for reporting insider transactions or changes in significant shareholdings by company directors and major shareholders. In the provided taxonomy, 'Director's Dealing' (DIRS) is the most accurate category for reports detailing personal share transactions by company directors and executives.
2024-01-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the change in share ownership by an executive (CEO Heo Tae-young) due to gifting shares to family members. This falls under the category of 'Director's Dealing' (insider trading/ownership changes by directors).
2023-12-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., gift, market sale), and updated share counts. This corresponds to the 'Major Shareholding Notification' category.
2023-12-28 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) for SD Biosensor. It details specific changes in share ownership by directors, executives, and major shareholders, including transaction dates, reasons (e.g., market sales, gifts), and updated ownership percentages. This falls under the category of 'Major Shareholding Notification' as it tracks changes in significant ownership levels.
2023-12-28 Korean
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from SD Biosensor regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to investment amounts and completion dates for a production facility. Since this is a specific regulatory disclosure regarding capital expenditure and facility investment updates, it falls under the general regulatory filing category as it does not fit into specific categories like M&A, dividends, or financial reports.
2023-12-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.